Search alternatives:
progress » process (Expand Search)
Showing 2,721 - 2,740 results of 12,642 for search 'detection (progress OR programs)', query time: 0.20s Refine Results
  1. 2721

    Barriers and contributions of rural community health workers in enabling cancer early detection and subsequent care in India: a qualitative study by Sathishrajaa Palaniraja, Katayoun Taghavi, Ishu Kataria, Kunal Oswal, Nandimandalam Venkata Vani, Asiya Ansari Liji, Hardika Parekh, Rita Isaac, Moni Kuriakose, Rajaraman Swaminathan, Rohit Rebello, Arnie Purushotham, Partha Basu, Richard Sullivan, Arunah Chandran

    Published 2025-04-01
    “…Results CHWs identified multiple barriers to cancer early detection and subsequent care delivery, organized into six overarching themes: (1) Program focus and awareness, (2) Treatment and referral challenges, (3) Acceptability and accessibility, (4) Rigid social customs and beliefs, (5) Lack of support at higher centers, and (6) Financial constraints. …”
    Get full text
    Article
  2. 2722

    Efficacy of Prostate Biopsies via Transperineal and Transrectal Routes for Significant Prostate Cancer Detection: A Multicenter Paired–Matched Study by Nahuel Paesano, Natàlia Picola, Jesús Muñoz-Rodriguez, Xavier Ruiz-Plazas, Marta V. Muñoz-Rivero, Ana Celma, Gemma García-de Manuel, Berta Miró, Pol Servian, José M. Abascal, Enrique Trilla, Juan Morote

    Published 2025-01-01
    “…<b>Methods</b>: In a prospective and multicenter trial conducted in an opportunistic early detection program for sPCa in Catalonia (Spain), between 2021 and 2023, 4029 men suspected of having PCa underwent multiparametric MRI followed by guided and systematic biopsies. …”
    Get full text
    Article
  3. 2723
  4. 2724
  5. 2725

    Temporal Effect on PD‐L1 Detection and Novel Insights Into Its Clinical Implications in Non–Small Cell Lung Cancer by Gopal P. Pathak, Rashmi Shah, Mathieu Castonguay, Angela Cheng, John Fris, Rowan Murphy, Gail Darling, Alexander Ednie, Daniel French, Harry Henteleff, Aneil Mujoomdar, Madelaine Plourde, Alison Wallace, Zhaolin Xu

    Published 2024-10-01
    “…Association of PD‐L1 with various driver mutations was explored, and implications of PD‐L1 in progression‐free survival (PFS) and overall survival (OS) were analyzed. …”
    Get full text
    Article
  6. 2726
  7. 2727
  8. 2728
  9. 2729
  10. 2730
  11. 2731

    THE ORGANIZATION WORKS TO IMPROVE THE CLINICAL AND ECONOMIC OUTCOMES OF CARE FOR PROSTATE CANCER by O. I. Apolikhin, A. V. Sivkov, I. V. Chernishov, M. I. Katibov, O. V. Zolotukhin, I. A. Shaderkin, S. A. Leonov, D. A. Vojtko, M. Y. Prosyannikov

    Published 2015-04-01
    “…Improving health outcomes in prostate cancer by developing optimal approaches to early detection, staging and treatment of disease. Materials and methods. …”
    Get full text
    Article
  12. 2732
  13. 2733

    Revolutionary advances in nanomaterials-based electrochemical biosensors for precise cancer biomarker analysis by Fatima Yaseen, Muhammad Hashim Khan, Shahaab Jilani, Ali Turab Jafry, Asim Yaqub, Huma Ajab

    Published 2025-12-01
    “…These indicators are becoming increasingly central within the patient care journey, increasing demand for technologies capable of precise and cost-effective test outcomes. Progress in sensing technology, coupled with the advent of new materials, innovative manufacturing methods, and enhanced precision in sampling, has markedly advanced the detection of cancer biomarkers. …”
    Get full text
    Article
  14. 2734

    NetChecker: enabling real-time and error-locatable runtime verification for programmable networks by Ying Yao, Le Tian, Yuxiang Hu

    Published 2025-06-01
    “…Experimental results in diverse network scenarios and open-source programs demonstrate that NetChecker is capable of detecting potential errors in real time and locating them without introducing significant overhead in programmable networks.…”
    Get full text
    Article
  15. 2735
  16. 2736
  17. 2737
  18. 2738

    Åfficacy of nutraceutical drug in the intermediate and wet forms of age-related macular degeneration by E. N. Eskina, A. V. Belogurova, A. A. Gvetadze, A. S. Smorchkova

    Published 2023-07-01
    “…The disease was considered to be progressing if signs of neovascular AMD were detected. …”
    Get full text
    Article
  19. 2739

    The prognostic value of circulating tumor DNA in malignant melanoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis by Lei Liu, Shufu Hou, Aiping Zhu, Bing Yan, Linchuan Li, Dandan Song

    Published 2025-01-01
    “…Furthermore, the detectability of ctDNA during treatment was also significantly associated with worse OS (HR = 4.57, 95% CI = 3.03–6.91, P &lt; 0.001) and PFS (HR = 3.79, 95% CI = 2.13–6.75, P &lt; 0.001).ConclusionsThis meta-analysis indicates that in MM patients receiving ICI therapy, detectable and high levels of ctDNA are significantly associated with poorer OS and PFS. …”
    Get full text
    Article
  20. 2740